We are live on ! Find out more
ALIM

Alimera Sciences

Delisted

ALIM was delisted on the 13th of September, 2024.

64 hedge funds and large institutions have $151M invested in Alimera Sciences in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

4% less funds holding

Funds holding: 6764 (-3)

10% less capital invested

Capital invested by funds: $167M → $151M (-$15.9M)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

30% less call options, than puts

Call options by funds: $259K | Put options by funds: $370K

Holders
64
Holders Change
-3
Holders Change %
-4.48%
% of All Funds
1.71%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.13%
New
7
Increased
27
Reduced
13
Closed
10
Calls
$259K
Puts
$370K
Net Calls
-$111K
Net Calls Change
-$755K
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Scale Management
California
$22.8M
DM
2
Deerfield Management
New York
$22.1M +$1.97M +24,983 +9%
PVMCI
3
Polaris Venture Management Co IV
Massachusetts
$15.8M
PAI
4
Palo Alto Investors
California
$15.1M
NRC
5
North Run Capital
Massachusetts
$14.9M +$4.45M +56,618 +40%
GPP
6
Great Point Partners
Connecticut
$8.68M -$4.66M -59,220 -34%
O
7
OrbiMed
New York
$7.51M
BFA
8
BlackRock Fund Advisors
California
$6.53M +$283K +3,602 +4%
PVI
9
Pura Vida Investments
New York
$5.59M +$855K +10,872 +17%
ACP
10
Acuta Capital Partners
California
$5.29M -$10.5K -133 -0.2%
Vanguard Group
11
Vanguard Group
Pennsylvania
$4.29M +$191K +2,433 +4%
Deutsche Bank
12
Deutsche Bank
Germany
$2.98M +$132K +1,672 +4%
SCM
13
Suffolk Capital Management
New York
$2.82M +$1.03M +13,113 +54%
Millennium Management
14
Millennium Management
New York
$2.04M +$276K +3,502 +15%
State Street
15
State Street
Massachusetts
$1.53M +$211K +2,687 +15%
CCMU
16
Cheyne Capital Management (UK)
United Kingdom
$1.51M +$1.18M +15,057 +297%
Northern Trust
17
Northern Trust
Illinois
$1.37M +$2.91K +37 +0.2%
PA
18
Perceptive Advisors
New York
$1.16M -$787K -10,000 -39%
BIT
19
BlackRock Institutional Trust
California
$1.09M +$34.5K +438 +3%
BCM
20
Bridgeway Capital Management
Texas
$758K
Geode Capital Management
21
Geode Capital Management
Massachusetts
$717K +$105K +1,329 +16%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$564K -$472 -6 -0.1%
HVC
23
Healthcare Value Capital
New Jersey
$501K
TCIM
24
TIAA CREF Investment Management
New York
$480K
ACA
25
Avoro Capital Advisors
New York
$408K -$3.11M -39,548 -88%

ALIM Hedge Fund Activity: Q1 2015 in Review

64 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q1 2015, worth a combined $151M — down 9.5% from $167M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ALIM and 7 opened new positions — a net loss of 3 holders — while 13 trimmed existing stakes and 27 added.

The largest buyer was North Run Capital, adding an estimated $4.45M. The largest seller was Great Point Partners, cutting an estimated $4.66M.

  • 64 institutional investors held Alimera Sciences (ALIM) as of Q1 2015, down from 67 in Q4 2014.
  • Funds reported $151M of Alimera Sciences stock for Q1 2015, down 9.5% quarter-over-quarter.
  • 7 funds opened new Alimera Sciences positions in Q1 2015 and 10 closed out, a net change of -3 holders.
  • The largest Alimera Sciences buyer in Q1 2015 was North Run Capital, an estimated $4.45M added.
  • The largest Alimera Sciences seller in Q1 2015 was Great Point Partners, an estimated $4.66M sold.

Based on aggregated 13F filings for Q1 2015.